<i>Adlercreutzia equolifaciens</i> Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease

<i>Adlercreutzia equolifaciens</i> Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease

Non-alcoholic fatty liver disease (NAFLD) affects about 20–40% of the adult population in high-income countries and is now a leading indication for liver transplantation and can lead to hepatocellular carcinoma. The link between gut microbiota dysbiosis and NAFLD is now clearly established. Through...

Full description

Bibliographic Details
Main Authors: Florian Plaza Oñate, Célia Chamignon, Sebastian D. Burz, Nicolas Lapaque, Magali Monnoye, Catherine Philippe, Maxime Bredel, Laurent Chêne, William Farin, Jean-Michel Paillarse, Jérome Boursier, Vlad Ratziu, Pierre-Yves Mousset, Joël Doré, Philippe Gérard, Hervé M. Blottière
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:International Journal of Molecular Sciences
Subjects:
NAFLD
gut microbiota
inflammation
metagenomics
live biotherapeutic product
Online Access:https://www.mdpi.com/1422-0067/24/15/12232

Similar Items

Similar Items